Published in Nature on March 20, 2011
CNVs: harbingers of a rare variant revolution in psychiatric genetics. Cell (2012) 4.81
The social motivation theory of autism. Trends Cogn Sci (2012) 4.07
Cell type–specific channelrhodopsin-2 transgenic mice for optogenetic dissection of neural circuitry function. Nat Methods (2011) 4.02
Autism-associated neuroligin-3 mutations commonly impair striatal circuits to boost repetitive behaviors. Cell (2014) 3.19
Autism-related deficits via dysregulated eIF4E-dependent translational control. Nature (2012) 3.13
Autistic-like social behaviour in Shank2-mutant mice improved by restoring NMDA receptor function. Nature (2012) 2.99
Interneuron dysfunction in psychiatric disorders. Nat Rev Neurosci (2012) 2.87
Negative allosteric modulation of the mGluR5 receptor reduces repetitive behaviors and rescues social deficits in mouse models of autism. Sci Transl Med (2012) 2.70
KCTD13 is a major driver of mirrored neuroanatomical phenotypes of the 16p11.2 copy number variant. Nature (2012) 2.47
Synaptic dysfunction in neurodevelopmental disorders associated with autism and intellectual disabilities. Cold Spring Harb Perspect Biol (2012) 2.42
The schizophrenia risk gene product miR-137 alters presynaptic plasticity. Nat Neurosci (2015) 2.37
Autistic-like behaviours and hyperactivity in mice lacking ProSAP1/Shank2. Nature (2012) 2.36
Corticostriatal connectivity and its role in disease. Nat Rev Neurosci (2013) 2.34
Activity-dependent neuronal signalling and autism spectrum disorder. Nature (2013) 2.23
Alterations in microRNA-124 and AMPA receptors contribute to social behavioral deficits in frontotemporal dementia. Nat Med (2014) 2.22
Protein interactome reveals converging molecular pathways among autism disorders. Sci Transl Med (2011) 2.04
Exaggerated translation causes synaptic and behavioural aberrations associated with autism. Nature (2012) 1.98
The 22q13.3 Deletion Syndrome (Phelan-McDermid Syndrome). Mol Syndromol (2011) 1.94
SHANK3 and IGF1 restore synaptic deficits in neurons from 22q13 deletion syndrome patients. Nature (2013) 1.93
SHANK3 overexpression causes manic-like behaviour with unique pharmacogenetic properties. Nature (2013) 1.86
Reduced excitatory neurotransmission and mild autism-relevant phenotypes in adolescent Shank3 null mutant mice. J Neurosci (2012) 1.71
Autism genetics: searching for specificity and convergence. Genome Biol (2012) 1.70
Modeling autism by SHANK gene mutations in mice. Neuron (2013) 1.64
Peripheral Mechanosensory Neuron Dysfunction Underlies Tactile and Behavioral Deficits in Mouse Models of ASDs. Cell (2016) 1.58
Autism-like syndrome is induced by pharmacological suppression of BET proteins in young mice. J Exp Med (2015) 1.58
Meta-analysis of SHANK Mutations in Autism Spectrum Disorders: a gradient of severity in cognitive impairments. PLoS Genet (2014) 1.57
Increased gene dosage of Ube3a results in autism traits and decreased glutamate synaptic transmission in mice. Sci Transl Med (2011) 1.48
Autism gene variant causes hyperserotonemia, serotonin receptor hypersensitivity, social impairment and repetitive behavior. Proc Natl Acad Sci U S A (2012) 1.48
Autism: a "critical period" disorder? Neural Plast (2011) 1.46
Advancing the understanding of autism disease mechanisms through genetics. Nat Med (2016) 1.45
From the genetic architecture to synaptic plasticity in autism spectrum disorder. Nat Rev Neurosci (2015) 1.44
Neural selectivity for communicative auditory signals in Phelan-McDermid syndrome. J Neurodev Disord (2016) 1.41
Deep molecular diversity of mammalian synapses: why it matters and how to measure it. Nat Rev Neurosci (2012) 1.40
JAKMIP1, a Novel Regulator of Neuronal Translation, Modulates Synaptic Function and Autistic-like Behaviors in Mouse. Neuron (2015) 1.40
Communication impairments in mice lacking Shank1: reduced levels of ultrasonic vocalizations and scent marking behavior. PLoS One (2011) 1.40
Imaging neural activity using Thy1-GCaMP transgenic mice. Neuron (2012) 1.40
Importance of Shank3 protein in regulating metabotropic glutamate receptor 5 (mGluR5) expression and signaling at synapses. J Biol Chem (2011) 1.40
Prevalence of SHANK3 variants in patients with different subtypes of autism spectrum disorders. Eur J Hum Genet (2012) 1.36
Diverse types of genetic variation converge on functional gene networks involved in schizophrenia. Nat Neurosci (2012) 1.34
Autism-associated mutations in ProSAP2/Shank3 impair synaptic transmission and neurexin-neuroligin-mediated transsynaptic signaling. J Neurosci (2012) 1.31
Autism as a disorder of prediction. Proc Natl Acad Sci U S A (2014) 1.31
Translational approaches to the biology of Autism: false dawn or a new era? Mol Psychiatry (2012) 1.26
Structural and synaptic plasticity in stress-related disorders. Rev Neurosci (2011) 1.26
Mouse model of Timothy syndrome recapitulates triad of autistic traits. Proc Natl Acad Sci U S A (2011) 1.26
Tipping the balance of autism risk: potential mechanisms linking pesticides and autism. Environ Health Perspect (2012) 1.25
Loss of predominant Shank3 isoforms results in hippocampus-dependent impairments in behavior and synaptic transmission. J Neurosci (2013) 1.24
Progress toward treatments for synaptic defects in autism. Nat Med (2013) 1.24
Excitatory/Inhibitory Balance and Circuit Homeostasis in Autism Spectrum Disorders. Neuron (2015) 1.24
Female Mecp2(+/-) mice display robust behavioral deficits on two different genetic backgrounds providing a framework for pre-clinical studies. Hum Mol Genet (2012) 1.23
Autism-relevant social abnormalities and cognitive deficits in engrailed-2 knockout mice. PLoS One (2012) 1.21
Adult restoration of Shank3 expression rescues selective autistic-like phenotypes. Nature (2016) 1.21
Marmosets: A Neuroscientific Model of Human Social Behavior. Neuron (2016) 1.18
Sensory integration in mouse insular cortex reflects GABA circuit maturation. Neuron (2014) 1.16
Inherited and de novo SHANK2 variants associated with autism spectrum disorder impair neuronal morphogenesis and physiology. Hum Mol Genet (2011) 1.15
Acute brain slice methods for adult and aging animals: application of targeted patch clamp analysis and optogenetics. Methods Mol Biol (2014) 1.14
Cntnap4 differentially contributes to GABAergic and dopaminergic synaptic transmission. Nature (2014) 1.14
Enhancement of inhibitory neurotransmission by GABAA receptors having α2,3-subunits ameliorates behavioral deficits in a mouse model of autism. Neuron (2014) 1.12
Neurobiology of rodent self-grooming and its value for translational neuroscience. Nat Rev Neurosci (2015) 1.12
Transcriptional and functional complexity of Shank3 provides a molecular framework to understand the phenotypic heterogeneity of SHANK3 causing autism and Shank3 mutant mice. Mol Autism (2014) 1.11
Generation of human striatal neurons by microRNA-dependent direct conversion of fibroblasts. Neuron (2014) 1.11
Neurobiology of obsessive-compulsive disorder: insights into neural circuitry dysfunction through mouse genetics. Curr Opin Neurobiol (2011) 1.07
Translational animal models of autism and neurodevelopmental disorders. Dialogues Clin Neurosci (2012) 1.06
Revitalizing psychiatric therapeutics. Neuropsychopharmacology (2014) 1.05
Gene × Environment interactions in autism spectrum disorders: role of epigenetic mechanisms. Front Psychiatry (2014) 1.05
Genes, circuits, and precision therapies for autism and related neurodevelopmental disorders. Science (2015) 1.05
Developmental vulnerability of synapses and circuits associated with neuropsychiatric disorders. J Neurochem (2013) 1.05
Progress in the genetics of polygenic brain disorders: significant new challenges for neurobiology. Neuron (2013) 1.05
Dendritic spine formation and synaptic function require neurobeachin. Nat Commun (2011) 1.05
Autism spectrum disorder causes, mechanisms, and treatments: focus on neuronal synapses. Front Mol Neurosci (2013) 1.04
Deep phenotyping: The details of disease. Nature (2015) 1.04
Cellular and synaptic network defects in autism. Curr Opin Neurobiol (2012) 1.02
Normal midbrain dopaminergic neuron development and function in miR-133b mutant mice. J Neurosci (2012) 1.02
Loss of CDKL5 disrupts kinome profile and event-related potentials leading to autistic-like phenotypes in mice. Proc Natl Acad Sci U S A (2012) 1.02
Social, communication, and cortical structural impairments in Epac2-deficient mice. J Neurosci (2012) 1.02
mGluR5-antagonist mediated reversal of elevated stereotyped, repetitive behaviors in the VPA model of autism. PLoS One (2011) 1.01
Pacemaker rate and depolarization block in nigral dopamine neurons: a somatic sodium channel balancing act. J Neurosci (2012) 1.01
High proportion of 22q13 deletions and SHANK3 mutations in Chinese patients with intellectual disability. PLoS One (2012) 1.01
Genetic depletion of brain 5HT reveals a common molecular pathway mediating compulsivity and impulsivity. J Neurochem (2012) 1.01
Is autism a disease of the cerebellum? An integration of clinical and pre-clinical research. Front Syst Neurosci (2013) 1.00
Epigenetic dysregulation of SHANK3 in brain tissues from individuals with autism spectrum disorders. Hum Mol Genet (2013) 0.99
Developmental delays and reduced pup ultrasonic vocalizations but normal sociability in mice lacking the postsynaptic cell adhesion protein neuroligin2. Behav Brain Res (2012) 0.99
Synaptic proteins and receptors defects in autism spectrum disorders. Front Cell Neurosci (2014) 0.98
Modeling psychiatric disorders for developing effective treatments. Nat Med (2015) 0.98
Autism-related behavioral abnormalities in synapsin knockout mice. Behav Brain Res (2012) 0.98
Lateral organization of the postsynaptic density. Mol Cell Neurosci (2011) 0.98
Altered mGluR5-Homer scaffolds and corticostriatal connectivity in a Shank3 complete knockout model of autism. Nat Commun (2016) 0.97
Translational Mouse Models of Autism: Advancing Toward Pharmacological Therapeutics. Curr Top Behav Neurosci (2016) 0.97
Frontotemporal degeneration, the next therapeutic frontier: molecules and animal models for frontotemporal degeneration drug development. Alzheimers Dement (2012) 0.96
Autism-like Deficits in Shank3-Deficient Mice Are Rescued by Targeting Actin Regulators. Cell Rep (2015) 0.96
Behavioral phenotypes of genetic mouse models of autism. Genes Brain Behav (2015) 0.96
Brain-specific Foxp1 deletion impairs neuronal development and causes autistic-like behaviour. Mol Psychiatry (2014) 0.96
Links between genetics and pathophysiology in the autism spectrum disorders. EMBO Mol Med (2011) 0.95
Dysregulation of group-I metabotropic glutamate (mGlu) receptor mediated signalling in disorders associated with Intellectual Disability and Autism. Neurosci Biobehav Rev (2014) 0.94
Circuit-selective striatal synaptic dysfunction in the Sapap3 knockout mouse model of obsessive-compulsive disorder. Biol Psychiatry (2013) 0.94
Toxicity of the flame-retardant BDE-49 on brain mitochondria and neuronal progenitor striatal cells enhanced by a PTEN-deficient background. Toxicol Sci (2013) 0.94
Following the genes: a framework for animal modeling of psychiatric disorders. BMC Biol (2011) 0.94
Optogenetic insights on the relationship between anxiety-related behaviors and social deficits. Front Behav Neurosci (2014) 0.94
Mice with Shank3 Mutations Associated with ASD and Schizophrenia Display Both Shared and Distinct Defects. Neuron (2015) 0.94
Phelan-McDermid Syndrome and SHANK3: Implications for Treatment. Neurotherapeutics (2015) 0.93
Autism-associated SHANK3 haploinsufficiency causes Ih channelopathy in human neurons. Science (2016) 0.93
Mutations of the X-linked genes encoding neuroligins NLGN3 and NLGN4 are associated with autism. Nat Genet (2003) 15.31
Functional impact of global rare copy number variation in autism spectrum disorders. Nature (2010) 14.66
Advances in autism genetics: on the threshold of a new neurobiology. Nat Rev Genet (2008) 12.18
Mutations in the gene encoding the synaptic scaffolding protein SHANK3 are associated with autism spectrum disorders. Nat Genet (2006) 11.14
Morris water maze: procedures for assessing spatial and related forms of learning and memory. Nat Protoc (2006) 7.64
Habits, rituals, and the evaluative brain. Annu Rev Neurosci (2008) 7.14
A neuroligin-3 mutation implicated in autism increases inhibitory synaptic transmission in mice. Science (2007) 6.64
Pten regulates neuronal arborization and social interaction in mice. Neuron (2006) 6.11
Postnatal neurodevelopmental disorders: meeting at the synapse? Science (2003) 5.71
Sociability and preference for social novelty in five inbred strains: an approach to assess autistic-like behavior in mice. Genes Brain Behav (2004) 5.15
Contribution of SHANK3 mutations to autism spectrum disorder. Am J Hum Genet (2007) 5.04
Disruption of neurexin 1 associated with autism spectrum disorder. Am J Hum Genet (2008) 5.04
Cortico-striatal synaptic defects and OCD-like behaviours in Sapap3-mutant mice. Nature (2007) 4.59
Binding of neuroligins to PSD-95. Science (1997) 3.88
Autism-like behavioral phenotypes in BTBR T+tf/J mice. Genes Brain Behav (2007) 3.76
Mutations in the SHANK2 synaptic scaffolding gene in autism spectrum disorder and mental retardation. Nat Genet (2010) 3.73
A synaptic trek to autism. Curr Opin Neurobiol (2009) 3.53
Molecular characterisation of the 22q13 deletion syndrome supports the role of haploinsufficiency of SHANK3/PROSAP2 in the major neurological symptoms. J Med Genet (2003) 3.25
When is the brain enlarged in autism? A meta-analysis of all brain size reports. Biol Psychiatry (2005) 2.94
Mouse neurexin-1alpha deletion causes correlated electrophysiological and behavioral changes consistent with cognitive impairments. Proc Natl Acad Sci U S A (2009) 2.93
GKAP, a novel synaptic protein that interacts with the guanylate kinase-like domain of the PSD-95/SAP90 family of channel clustering molecules. J Cell Biol (1997) 2.92
Slitrk5 deficiency impairs corticostriatal circuitry and leads to obsessive-compulsive-like behaviors in mice. Nat Med (2010) 2.75
Neuroligin-1 deletion results in impaired spatial memory and increased repetitive behavior. J Neurosci (2010) 2.57
Identification of a recurrent breakpoint within the SHANK3 gene in the 22q13.3 deletion syndrome. J Med Genet (2005) 2.54
How the brain processes social information: searching for the social brain. Annu Rev Neurosci (2004) 2.44
Novel de novo SHANK3 mutation in autistic patients. Am J Med Genet B Neuropsychiatr Genet (2009) 2.43
Smaller dendritic spines, weaker synaptic transmission, but enhanced spatial learning in mice lacking Shank1. J Neurosci (2008) 2.27
SAPAPs. A family of PSD-95/SAP90-associated proteins localized at postsynaptic density. J Biol Chem (1997) 2.23
Genetics of human social behavior. Neuron (2010) 2.07
The NMDA-to-AMPA ratio at synapses onto layer 2/3 pyramidal neurons is conserved across prefrontal and visual cortices. J Neurophysiol (2003) 2.01
Characteristics and concordance of autism spectrum disorders among 277 twin pairs. Arch Pediatr Adolesc Med (2009) 1.99
Striatal volume on magnetic resonance imaging and repetitive behaviors in autism. Biol Psychiatry (2005) 1.94
The cerebral metabolic landscape in autism. Intercorrelations of regional glucose utilization. Arch Neurol (1988) 1.86
An MRI study of the basal ganglia in autism. Prog Neuropsychopharmacol Biol Psychiatry (1999) 1.82
Changes in the developmental trajectories of striatum in autism. Biol Psychiatry (2009) 1.71
The role of protein synthesis in striatal long-term depression. J Neurosci (2006) 1.34
Visuospatial processing and the function of prefrontal-parietal networks in autism spectrum disorders: a functional MRI study. Am J Psychiatry (2006) 1.26
Differential mRNA expression and protein localization of the SAP90/PSD-95-associated proteins (SAPAPs) in the nervous system of the mouse. J Comp Neurol (2004) 1.25
Genetic evaluation of pervasive developmental disorders: the terminal 22q13 deletion syndrome may represent a recognizable phenotype. Clin Genet (2000) 1.22
Presynaptic actions of carbachol and adenosine on corticostriatal synaptic transmission studied in vitro. J Neurosci (1988) 1.16
Neurogenetics: advancing the "next-generation" of brain research. Neuron (2010) 1.16
Long-term in vivo imaging of experience-dependent synaptic plasticity in adult cortex. Nature (2002) 11.85
In vivo light-induced activation of neural circuitry in transgenic mice expressing channelrhodopsin-2. Neuron (2007) 7.59
A transcription activator-like effector toolbox for genome engineering. Nat Protoc (2012) 6.81
Cortico-striatal synaptic defects and OCD-like behaviours in Sapap3-mutant mice. Nature (2007) 4.59
Cell type–specific channelrhodopsin-2 transgenic mice for optogenetic dissection of neural circuitry function. Nat Methods (2011) 4.02
Next-generation optical technologies for illuminating genetically targeted brain circuits. J Neurosci (2006) 3.95
Sustained axon regeneration induced by co-deletion of PTEN and SOCS3. Nature (2011) 3.18
Dynamic remodeling of dendritic arbors in GABAergic interneurons of adult visual cortex. PLoS Biol (2005) 2.61
Genetic evidence that relative synaptic efficacy biases the outcome of synaptic competition. Nature (2003) 2.51
Optogenetic stimulation of lateral orbitofronto-striatal pathway suppresses compulsive behaviors. Science (2013) 2.21
Habenula "cholinergic" neurons co-release glutamate and acetylcholine and activate postsynaptic neurons via distinct transmission modes. Neuron (2011) 2.14
Improved expression of halorhodopsin for light-induced silencing of neuronal activity. Brain Cell Biol (2008) 2.12
Postsynaptic requirement for Abl kinases in assembly of the neuromuscular junction. Nat Neurosci (2003) 2.03
The primordial, blue-cone color system of the mouse retina. J Neurosci (2005) 1.94
Visual function in mice with photoreceptor degeneration and transgenic expression of channelrhodopsin 2 in ganglion cells. J Neurosci (2010) 1.87
Synaptic dynamism measured over minutes to months: age-dependent decline in an autonomic ganglion. Nat Neurosci (2003) 1.77
Selective optical drive of thalamic reticular nucleus generates thalamic bursts and cortical spindles. Nat Neurosci (2011) 1.74
The histone deacetylase HDAC4 connects neural activity to muscle transcriptional reprogramming. J Biol Chem (2007) 1.70
Two-photon imaging reveals somatodendritic chloride gradient in retinal ON-type bipolar cells expressing the biosensor Clomeleon. Neuron (2006) 1.63
Calcium channel alpha2delta1 subunit mediates spinal hyperexcitability in pain modulation. Pain (2006) 1.61
Progressive NKCC1-dependent neuronal chloride accumulation during neonatal seizures. J Neurosci (2010) 1.50
Single-neuron labeling with inducible Cre-mediated knockout in transgenic mice. Nat Neurosci (2008) 1.43
The chloride transporter Na(+)-K(+)-Cl- cotransporter isoform-1 contributes to intracellular chloride increases after in vitro ischemia. J Neurosci (2006) 1.42
Differences in cortical versus subcortical GABAergic signaling: a candidate mechanism of electroclinical uncoupling of neonatal seizures. Neuron (2009) 1.42
Imaging neural activity using Thy1-GCaMP transgenic mice. Neuron (2012) 1.40
Effects of prey refuges on a predator-prey model with a class of functional responses: the role of refuges. Math Biosci (2009) 1.38
Relationship between availability of NMDA receptor subunits and their expression at the synapse. J Neurosci (2002) 1.33
Downregulation of NR3A-containing NMDARs is required for synapse maturation and memory consolidation. Neuron (2009) 1.31
Dopamine modulation of GABA tonic conductance in striatal output neurons. J Neurosci (2009) 1.30
cMET and phospho-cMET protein levels in breast cancers and survival outcomes. Clin Cancer Res (2012) 1.28
Close homolog of L1 modulates area-specific neuronal positioning and dendrite orientation in the cerebral cortex. Neuron (2004) 1.28
Expression of distinct alpha subunits of GABAA receptor regulates inhibitory synaptic strength. J Neurophysiol (2004) 1.28
PSD93 regulates synaptic stability at neuronal cholinergic synapses. J Neurosci (2004) 1.26
Monoacylglycerol lipase is a therapeutic target for Alzheimer's disease. Cell Rep (2012) 1.25
The effects of amyloid precursor protein on postsynaptic composition and activity. J Biol Chem (2009) 1.25
Differential mRNA expression and protein localization of the SAP90/PSD-95-associated proteins (SAPAPs) in the nervous system of the mouse. J Comp Neurol (2004) 1.25
Imaging synaptic inhibition in transgenic mice expressing the chloride indicator, Clomeleon. Brain Cell Biol (2008) 1.21
ChAT-ChR2-EYFP mice have enhanced motor endurance but show deficits in attention and several additional cognitive domains. J Neurosci (2013) 1.20
NMDA receptors increase the size of GABAergic terminals and enhance GABA release. J Neurosci (2005) 1.19
The role of the PDZ protein GIPC in regulating NMDA receptor trafficking. J Neurosci (2007) 1.15
Acute brain slice methods for adult and aging animals: application of targeted patch clamp analysis and optogenetics. Methods Mol Biol (2014) 1.14
Functional consequences of mutations in postsynaptic scaffolding proteins and relevance to psychiatric disorders. Annu Rev Neurosci (2012) 1.13
Reduced glutathione depletion causes necrosis and sensitization to tumor necrosis factor-alpha-induced apoptosis in cultured mouse hepatocytes. Hepatology (2002) 1.13
Apolipoprotein E receptor 2 interactions with the N-methyl-D-aspartate receptor. J Biol Chem (2005) 1.11
PSD-95 regulates NMDA receptors in developing cerebellar granule neurons of the rat. J Physiol (2003) 1.09
NMDA receptor subtypes at autaptic synapses of cerebellar granule neurons. J Neurophysiol (2006) 1.09
Exercise modulation of the host-tumor interaction in an orthotopic model of murine prostate cancer. J Appl Physiol (1985) (2012) 1.08
FE65 interaction with the ApoE receptor ApoEr2. J Biol Chem (2006) 1.08
Neurobiology of obsessive-compulsive disorder: insights into neural circuitry dysfunction through mouse genetics. Curr Opin Neurobiol (2011) 1.07
Pharmacogenomic effects of apolipoprotein e on intracerebral hemorrhage. Stroke (2008) 1.07
3D-reconstruction and functional properties of GFP-positive and GFP-negative granule cells in the fascia dentata of the Thy1-GFP mouse. Hippocampus (2008) 1.06
Silent synapses in developing cerebellar granule neurons. J Neurophysiol (2002) 1.06
Ubiquilin-1 regulates nicotine-induced up-regulation of neuronal nicotinic acetylcholine receptors. J Biol Chem (2005) 1.05
Candidate genes and functional noncoding variants identified in a canine model of obsessive-compulsive disorder. Genome Biol (2014) 1.04
Regulation of synaptic growth and maturation by a synapse-associated E3 ubiquitin ligase at the neuromuscular junction. J Cell Biol (2007) 1.04
ERalpha suppresses slug expression directly by transcriptional repression. Biochem J (2008) 1.03
Cellular and synaptic network defects in autism. Curr Opin Neurobiol (2012) 1.02
Sapap3 deletion causes mGluR5-dependent silencing of AMPAR synapses. J Neurosci (2011) 1.02
Normal midbrain dopaminergic neuron development and function in miR-133b mutant mice. J Neurosci (2012) 1.02
Sapap3 deletion anomalously activates short-term endocannabinoid-mediated synaptic plasticity. J Neurosci (2011) 1.02
Labeling neurons in vivo for morphological and functional studies. Curr Opin Neurobiol (2004) 1.02
Next-generation transgenic mice for optogenetic analysis of neural circuits. Front Neural Circuits (2013) 1.01
GABA(A) receptor beta3 subunit deletion decreases alpha2/3 subunits and IPSC duration. J Neurophysiol (2003) 1.01
Development of transgenic animals for optogenetic manipulation of mammalian nervous system function: progress and prospects for behavioral neuroscience. Behav Brain Res (2013) 1.00
SynCAM1 recruits NMDA receptors via protein 4.1B. Mol Cell Neurosci (2009) 0.99
Imaging synaptic inhibition throughout the brain via genetically targeted Clomeleon. Brain Cell Biol (2008) 0.99
Cortical control of affective networks. J Neurosci (2013) 0.97
Association of NR3A with the N-methyl-D-aspartate receptor NR1 and NR2 subunits. Mol Pharmacol (2002) 0.96
Genetic perturbation of postsynaptic activity regulates synapse elimination in developing cerebellum. Proc Natl Acad Sci U S A (2009) 0.96
Glutamatergic Synaptic Dysfunction and Obsessive-Compulsive Disorder. Curr Chem Genomics (2008) 0.95
Radiation dose exposure for lumbar spine epidural steroid injections: a comparison of conventional fluoroscopy data and CT fluoroscopy techniques. AJR Am J Roentgenol (2011) 0.95
Fluorescent labeling of newborn dentate granule cells in GAD67-GFP transgenic mice: a genetic tool for the study of adult neurogenesis. PLoS One (2010) 0.95
Optical inhibition of motor nerve and muscle activity in vivo. Muscle Nerve (2013) 0.94
Brain natriuretic peptide improves long-term functional recovery after acute CNS injury in mice. J Neurotrauma (2010) 0.93
Lamina-specific distribution of Synaptopodin, an actin-associated molecule essential for the spine apparatus, in identified principal cell dendrites of the mouse hippocampus. J Comp Neurol (2005) 0.93
Enhanced pre-synaptic glutamate release in deep-dorsal horn contributes to calcium channel alpha-2-delta-1 protein-mediated spinal sensitization and behavioral hypersensitivity. Mol Pain (2009) 0.91
Inhibition of expression of the chromatin remodeling gene, SNF2L, selectively leads to DNA damage, growth inhibition, and cancer cell death. Mol Cancer Res (2009) 0.91
Differential regulation of the postsynaptic clustering of γ-aminobutyric acid type A (GABAA) receptors by collybistin isoforms. J Biol Chem (2011) 0.90
Xenon neuroprotection in experimental stroke: interactions with hypothermia and intracerebral hemorrhage. Anesthesiology (2012) 0.89
Intersectional Cre driver lines generated using split-intein mediated split-Cre reconstitution. Sci Rep (2012) 0.88
LNX1 is a perisynaptic Schwann cell specific E3 ubiquitin ligase that interacts with ErbB2. Mol Cell Neurosci (2005) 0.87
In vivo imaging of juxtaglomerular neuron turnover in the mouse olfactory bulb. Proc Natl Acad Sci U S A (2006) 0.87
Pulse labeling and long-term tracing of newborn neurons in the adult subgranular zone. Cell Res (2010) 0.87
Integrative network-based Bayesian analysis of diverse genomics data. BMC Bioinformatics (2013) 0.86
Imaging synaptic inhibition with the genetically encoded chloride indicator Clomeleon. Cold Spring Harb Protoc (2011) 0.86
Annual Research Review: Transgenic mouse models of childhood-onset psychiatric disorders. J Child Psychol Psychiatry (2011) 0.84
ApolipoproteinE mimetic peptides improve outcome after focal ischemia. Exp Neurol (2012) 0.83
Fence-sitters protect cooperation in complex networks. Phys Rev E Stat Nonlin Soft Matter Phys (2013) 0.81
pH-sensitive NMDA inhibitors improve outcome in a murine model of SAH. Neurocrit Care (2014) 0.80
Corrigendum: Optogenetic dissection of ictal propagation in the hippocampal-entorhinal cortex structures. Nat Commun (2016) 0.80
SnapShot: Autism and the synapse. Cell (2011) 0.79
Striatopallidal dysfunction underlies repetitive behavior in Shank3-deficient model of autism. J Clin Invest (2017) 0.78